Aquestive Therapeutics, Inc. Annual Return On Assets in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2019 to 2023.
  • Aquestive Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -34 %, a 64.6% decline year-over-year.
  • Aquestive Therapeutics, Inc. annual Return On Assets for 2023 was -13.4 %, a 86.4% increase from 2022.
  • Aquestive Therapeutics, Inc. annual Return On Assets for 2022 was -98.1 %, a 10.9% increase from 2021.
  • Aquestive Therapeutics, Inc. annual Return On Assets for 2021 was -110 %, a 19.2% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -13.4 +84.8 +86.4% Jan 1, 2023 Dec 31, 2023
2022 -98.1 +12 +10.9% Jan 1, 2022 Dec 31, 2022
2021 -110 -17.7 -19.2% Jan 1, 2021 Dec 31, 2021
2020 -92.5 +15.4 +14.3% Jan 1, 2020 Dec 31, 2020
2019 -108 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.